News Release
September 18, 2007
Contact: Maureen McGuire, 860-679-4523
e-mail:
mmcguire@nso.uchc.edu
UConn Cancer Experts Answer Questions About
Genetic Counseling & Testing
Answers Aren’t Always Black and White;
Prevention Depends On Multiple Factors
FARMINGTON, CONN. – It seems so easy. The next time you are
shopping online for books or holiday gifts, you can also order a kit
containing a blood test to determine your risk of breast and ovarian
cancer – two of the most dreaded women’s cancers.
Experts at the University of Connecticut Health Center, however,
warn that this is not an optimal approach to understand your breast
and ovarian cancer risk.
“I would never recommend genetic testing outside the context of
comprehensive, confidential genetic counseling that gives a woman a
thorough look at her unique risk profile,” said Molly Brewer, M.D.,
director of the Division of Gynecologic Oncology at the UConn Health
Center’s Neag Comprehensive Cancer Center.
“Genetic counseling is a smart choice for any woman who has a
significant family history of cancer or other risk factors. It can
help her understand her estimated probability of developing cancer
and what she can do to lower her risk,” Dr. Brewer said. “However,
genetic testing is not necessary for everyone.”
Under Dr. Brewer’s leadership, the Health Center is starting a
new Women’s Cancer Prevention Program. The program includes genetic
counseling services and offers women a thorough approach to
understand their risk factors and to create personalized prevention
strategies.
“There is so much more to cancer prevention than testing. Our
program follows women continuously, offering new approaches to
prevention that range from help with lifestyle changes to
opportunities to participate in clinical studies aimed at
prevention,” Dr. Brewer said.
What is Genetic Testing?
“After careful assessment of both family and personal risk
factors, genetic testing may be recommended,” explained Robert
Greenstein, M.D., director of the Health Center’s Division of Human
Genetics.
Researchers have identified two major breast and ovarian
susceptibility genes, BRCA1 and BRCA2. The lifetime
risk for breast cancer for women with BRCA mutations is
between 50 and 85 percent. The lifetime risk for ovarian cancer
varies even more significantly between families, but may range
between 20 and 60 percent, he said.
The decision to participate in BRCA1 or BRCA2
testing may be a difficult one, stressed genetic counselor Robin
Schwartz, M.S.
“For some women, the choice is straightforward, for others, it is
more complex. The results can also be confusing. The presence of
either of these genes does not guarantee that a woman will develop
cancer, nor does the absence guarantee that she won’t,” she said.
“We offer recommendations based on probability,” Schwartz added,
noting that recommendations range from frequent screening tests and
lifestyle changes to medications or risk-reducing surgery.
“Plus, it is important to remember that some hereditary cancers
are caused by susceptibility genes that have not yet been
identified,” she said. “So, individuals without a mutation may still
be at risk. Test results have to be interpreted for each patient. In
addition, some individuals may have uncommon mutations that are not
likely to be detected with current technology.”
What is Genetic Counseling?
“Information can be power. Knowing an estimated risk of
developing a hereditary cancer can help people make important
decisions regarding lifestyle, frequency of screening tests,
medication, and other options,” said Health Center genetic counselor
Jennifer Stroop.
Genetic counseling includes a complete evaluation of each
patient’s family and personal medical history. Individualized
genetic cancer risk assessment is calculated for each person. This
is followed by a thorough discussion of appropriate screening and
management options.
Who Should Consider the Women’s Cancer Prevention Program?
The new Women’s Cancer Prevention Program at UConn Health Center
can be helpful to any woman who is concerned about her risk of
developing cancer. Risk factors to consider include:
- A personal cancer diagnosis at an early age (under 50)
- Significant family history of cancer, affecting more than
one close relative – parent, sibling, child, grandparent, aunt
or uncle, on either side of the family
- Clusters of cancers in families including pancreatic,
stomach or brain cancer
- Relatives with a known genetic predisposition to cancer
“By helping women understand their risk of cancer, or recurrence
of cancer, we can work with you to create meaningful prevention
strategies,” Dr. Brewer explained. “Because we are a university
hospital, we also have many resources to draw upon to help women
make informed decisions,” she added.
Caregivers in the Women’s Cancer Prevention Program include Dr.
Brewer, genetic counselors Schwartz and Stroop, medical oncologists,
breast health specialists, a social worker, psychologist,
nutritionist and more.
“Our goal is to help women manage all facets of cancer
prevention, from health care decisions to lifestyle changes,” Dr.
Brewer added.
The University of Connecticut Health Center includes the schools of
medicine and dental medicine, the UConn Medical Group, University
Dentists, and John Dempsey Hospital, a Solucient Top 100 Hospital®
2006. Founded in 1961, the Health Center pursues a mission of
providing outstanding health care education in an environment of
exemplary patient care, research and public service. To learn more about
the UConn Health Center, visit our website at
www.uchc.edu.
Note: News professionals are invited to visit the Office of
Communications homepage at
www.uchc.edu/ocomm/ for archived news releases and other
information.
|